Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
With the growth of immunotherapies in recent years as an effective melanoma treatment option, there are still patients who do not respond well to immunotherapies. Hildur Helgadottir, MD,…
A research team from Brazil evaluated the link between anxiety and depression — nonmotor symptoms of Parkinson’s disease (PD) — and freezing of gait. They found that roughly…
Interim results from the preliminary analysis of the JAVELIN-Renal 101 trial suggest that adding immunotherapy to a targeted agent appears to significantly improve progression-free survival (PFS) when compared with a…
Hungarian researchers, in collaboration with the Allen Institute for Brain Science, a Seattle-based nonprofit, discovered a new type of brain cell that has not yet been observed in…
Vanderbilt neurosurgeons fit DBS electrodes with extraordinary precision on patients to treat Parkinson’s disease tremors that cannot be treated with medications.
A millimeter-scale soft robotic spider for medical applications built by Harvard researchers has capabilities previously possible only on a larger scale.
